Comparison of equine-induced pluripotent stem cell characteristics induced on different cell adhesion substrates.
Authors: Kushida Chiho, Usui Tatsuya, Tamura Norihisa, Kasashima Yoshinori, Sato Kota, Arai Katsuhiko
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary: Optimising Equine Induced Pluripotent Stem Cell Generation Through Substrate Selection Researchers compared two cell adhesion substrates for reprogramming equine embryonic skin fibroblasts into induced pluripotent stem cells (iPSCs), a critical step towards regenerative medicine applications in horses. Laminin-511 (the E8 fragment) proved substantially more efficient at generating iPSC colonies than Geltrex-based laminin-111, with additional improvement achieved by supplementing both substrates with small molecular compounds; iPSCs grown on laminin-511 also demonstrated notably higher proliferation rates. Gene expression analysis revealed that whilst conventional pluripotency markers remained similar between the two substrates, DPPA3 emerged as a particularly sensitive marker for equine iPSC status, and laminin-511-derived cells expressed significantly higher levels of integrin subunits (ITGA3 and ITGA7), indicating stronger substrate binding and cellular stability. Conversely, laminin-111-based iPSCs showed superior capacity for spontaneous differentiation into the three embryonic germ layers in vitro, suggesting a potential trade-off between generation efficiency and differentiation plasticity. For equine practitioners involved in regenerative medicine research and development—whether in therapeutic applications for soft tissue repair or performance-related injuries—these findings provide evidence that substrate selection fundamentally influences iPSC quality, with laminin-511 offering superior generation and expansion whilst laminin-111 may be preferable when downstream differentiation capacity is the priority.
Read the full abstract on PubMed
Practical Takeaways
- •Laminin-511 (E8 fragment) is the superior substrate for generating equine iPSCs with better reprogramming efficiency and proliferation characteristics for potential therapeutic applications
- •While eiPSC-511 shows superior growth properties, eiPSC-111 may be advantageous if germ layer differentiation capacity is the clinical goal, allowing substrate selection based on intended application
- •DPPA3 serves as a reliable marker for confirming equine iPSC pluripotency status, useful for quality control in regenerative medicine protocols
Key Findings
- •eiPSC-511 (laminin-511 substrate) demonstrated higher reprogramming efficiency and growth activity compared to eiPSC-111 (Geltrex/laminin-111 substrate)
- •DPPA3 expression was significantly upregulated in both iPSC lines, identifying it as a sensitive pluripotency marker for equine iPSC
- •eiPSC-511 showed significantly increased mRNA levels of ITGA3 and ITGA7 integrins, suggesting stronger substrate binding than eiPSC-111
- •eiPSC-111 demonstrated enhanced in vitro differentiation capacity into three germ layers despite no significant differences in teratoma histology